Tom Wilemon

February 20, 2020

Symposium to focus on stem cell transplant, cellular therapies

New therapies that re-engineer patients’ T-cells to target cancer and advances in stem cell transplantations that make it easier for patients to be matched with donors are among the topics at an upcoming symposium.

By Tom Wilemon
February 13, 2020

Advocacy group’s gift boosts lung cancer research efforts

An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.

By Tom Wilemon
February 6, 2020

Stem cell recipient and donor meet in person for first time

Josh Ferris was sitting in a hunting blind on Nov. 15, 2018, the first day of deer season in Michigan and the one-year anniversary of his stem cell donation, when he received an email from Todd Adams of Nashville, the recipient of his life-saving gift.

By Tom Wilemon
February 5, 2020

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

By Tom Wilemon
February 5, 2020

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

By Tom Wilemon
January 29, 2020

Cancer Center hosting symposium for rural health care providers

Vanderbilt-Ingram Cancer Center will host a two-day symposium for health care professionals working with rural populations in February.

By Tom Wilemon
January 16, 2020

Journey Home Project supports first CAR-T infusion at VA hospital

The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville.
By Tom Wilemon
January 16, 2020

ACMG issues statement on breast cancer genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
By Tom Wilemon
January 9, 2020

Park named interim Hematology and Oncology director

Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.
By Tom Wilemon
January 9, 2020

Impact of weight gain from early to middle adulthood explored

An analysis of weight gain occurring from early to middle adulthood indicates that the added weight is associated with multiple health outcomes in later life.
By Tom Wilemon
December 13, 2019

The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
By Tom Wilemon
December 12, 2019

Richmond receives legacy award from Society for Leukocyte Biology

Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.
By Tom Wilemon
1 … 18 19 20 21 22 … 37